Ottawa to extend $1.2B in funding for home care, mental health services - CTV News

The federal government says it plans to extend funding to provinces and territories for mental health, addictions and home care by one year. Health Minister Marjorie Michel says in a social media post that the announced extension represents $1.2 billion in funding.

OTTAWA - The federal government says it plans to extend funding to provinces and territories for mental health, addictions and home care by one year.

OTTAWA - The federal government says it plans to extend funding to provinces and territories for mental health, addictions and home care by one year.

Federal Minister of Health Marjorie Michel, centre, addresses the media with her provincial health minister colleagues at a wrap-up news conference in Calgary, Friday, Oct. OTTAWA - The federal government says it plans to extend funding to provinces and territories for mental health, addictions and home care by one year. Health Minister Marjorie Michel says in a social media post that the announced extension represents $1.2 billion in funding.

OTTAWA — The federal government says it plans to extend funding to provinces and territories for mental health, addictions and home care by one year. Health Minister Marjorie Michel says in a social media post that the announced extension represents $1.2 billion in funding. Michel’s post comes after provincial health ministers expressed worry about “profound and negative” effects on patients and health care jobs if the federal funding agreements aren’t renewed in this year’s budget. Provinces and territories also raised concerns earlier this month about the future of the Canada Health Transfer. The federal budget will be tabled later this fall. Provincial and territorial health ministers are set to meet Thursday in Winnipeg, while Michel is to co-chair Friday’s meeting. This report by The Canadian Press was first published Oct. 14, 2026. The Canadian Press

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.